Skip to main content
Top
Published in: Current Pain and Headache Reports 11/2023

01-09-2023 | Migraine | Chronic Daily Headache (S-J Wang and S-P Chen, Section Editors)

Overlap and Differences in Migraine and Idiopathic Intracranial Hypertension

Authors: Sweta Sengupta, Jaskiran Vidwan

Published in: Current Pain and Headache Reports | Issue 11/2023

Login to get access

Abstract

Purpose of Review

Migraine and idiopathic intracranial hypertension (IIH) are increasingly encountered but remain enigmatic. This review compares the similarities and differences of the diagnostic criteria, pathophysiology, and risk factors for chronic migraine and IIH.

Recent Findings

While migraine and IIH are distinct diseases, both conditions are frequently found concurrently and may share a link. Increased intracranial pressure (ICP) in those with or without pre-existing migraine may present with migraine-like headaches and contribute to migraine chronification. Increased intracranial pressure may be a coincidental occurrence in patients with migraine and normalization of pressure does not always translate to headache improvement. Limited information is available regarding the standard of treatment for patients with chronic migraine and IIH without papilledema.

Summary

There continues to be controversy over the normal range of cerebral spinal fluid (CSF) values. Recognizing the concurrence of both conditions advances our understanding of headache pathology and demonstrates a striking need for more research.
Literature
1.
go back to reference Munakata J, Hazard E, Serrano D, Klingman D, Rupnow MFT, Tierce J, et al. Economic burden of transformed migraine: results from the American Migraine Prevalence and Prevention (AMPP) Study. Headache: The Journal of Head and Face Pain. 2009;49(4):498–508. Munakata J, Hazard E, Serrano D, Klingman D, Rupnow MFT, Tierce J, et al. Economic burden of transformed migraine: results from the American Migraine Prevalence and Prevention (AMPP) Study. Headache: The Journal of Head and Face Pain. 2009;49(4):498–508.
2.
go back to reference •• Mollan SP, Grech O, Sinclair AJ. Headache attributed to idiopathic intracranial hypertension and persistent post-idiopathic intracranial hypertension headache: a narrative review. Headache. 2021;61(6):808–16. A comprehensive review of persistent post-IIH headache. •• Mollan SP, Grech O, Sinclair AJ. Headache attributed to idiopathic intracranial hypertension and persistent post-idiopathic intracranial hypertension headache: a narrative review. Headache. 2021;61(6):808–16. A comprehensive review of persistent post-IIH headache.
3.
go back to reference Blanch RJ, Vasseneix C, Liczkowski A, Yiangou A, Aojula A, Micieli JA, et al. Differing presenting features of idiopathic intracranial hypertension in the UK and US. Eye (Lond). 2019;33(6):1014–9.PubMedCrossRef Blanch RJ, Vasseneix C, Liczkowski A, Yiangou A, Aojula A, Micieli JA, et al. Differing presenting features of idiopathic intracranial hypertension in the UK and US. Eye (Lond). 2019;33(6):1014–9.PubMedCrossRef
4.
go back to reference Hoffmann J, Mollan SP, Paemeleire K, Lampl C, Jensen RH, Sinclair AJ. European Headache Federation guideline on idiopathic intracranial hypertension. J Headache Pain. 2018;19(1):93.PubMedPubMedCentralCrossRef Hoffmann J, Mollan SP, Paemeleire K, Lampl C, Jensen RH, Sinclair AJ. European Headache Federation guideline on idiopathic intracranial hypertension. J Headache Pain. 2018;19(1):93.PubMedPubMedCentralCrossRef
5.
go back to reference Zur D, Naftaliev E, Kesler A. Evidence of multidomain mild cognitive impairment in idiopathic intracranial hypertension. J Neuroophthalmol. 2015;35(1):26–30.PubMedCrossRef Zur D, Naftaliev E, Kesler A. Evidence of multidomain mild cognitive impairment in idiopathic intracranial hypertension. J Neuroophthalmol. 2015;35(1):26–30.PubMedCrossRef
6.
go back to reference Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018;38(1):1–211. Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018;38(1):1–211.
7.
go back to reference Chalmer MA, Hansen TF, Lebedeva ER, Dodick DW, Lipton RB, Olesen J. Proposed new diagnostic criteria for chronic migraine. Cephalalgia. 2020;40(4):399–406.PubMedCrossRef Chalmer MA, Hansen TF, Lebedeva ER, Dodick DW, Lipton RB, Olesen J. Proposed new diagnostic criteria for chronic migraine. Cephalalgia. 2020;40(4):399–406.PubMedCrossRef
8.
go back to reference Digre KB. Idiopathic intracranial hypertension headache. Curr Pain Headache Rep. 2002;6(3):217–25.PubMedCrossRef Digre KB. Idiopathic intracranial hypertension headache. Curr Pain Headache Rep. 2002;6(3):217–25.PubMedCrossRef
9.
go back to reference Funnell JP, Craven CL, D’Antona L, Thompson SD, Chari A, Thorne L, et al. Intracranial pressure in patients with papilloedema. Acta Neurol Scand. 2018;138(2):137–42.PubMedCrossRef Funnell JP, Craven CL, D’Antona L, Thompson SD, Chari A, Thorne L, et al. Intracranial pressure in patients with papilloedema. Acta Neurol Scand. 2018;138(2):137–42.PubMedCrossRef
10.
go back to reference Digre KB, Nakamoto BK, Warner JEA, Langeberg WJ, Baggaley SK, Katz BJ. A comparison of idiopathic intracranial hypertension with and without papilledema. Headache. 2009;49(2):185–93. Digre KB, Nakamoto BK, Warner JEA, Langeberg WJ, Baggaley SK, Katz BJ. A comparison of idiopathic intracranial hypertension with and without papilledema. Headache. 2009;49(2):185–93.
11.
go back to reference Digre KB, Nakamoto BK, Warner JE, Langeberg WJ, Baggaley SK, Katz BJ. A comparison of idiopathic intracranial hypertension with and without papilledema. Headache. 2009;49(2):185–93.PubMedPubMedCentralCrossRef Digre KB, Nakamoto BK, Warner JE, Langeberg WJ, Baggaley SK, Katz BJ. A comparison of idiopathic intracranial hypertension with and without papilledema. Headache. 2009;49(2):185–93.PubMedPubMedCentralCrossRef
12.
go back to reference Wang SJ, Silberstein SD, Patterson S, Young WB. Idiopathic intracranial hypertension without papilledema: a case-control study in a headache center. Neurology. 1998;51(1):245–9.PubMedCrossRef Wang SJ, Silberstein SD, Patterson S, Young WB. Idiopathic intracranial hypertension without papilledema: a case-control study in a headache center. Neurology. 1998;51(1):245–9.PubMedCrossRef
13.
go back to reference •• Favoni V, Pierangeli G, Toni F, Cirillo L, La Morgia C, Abu-Rumeileh S, et al. Idiopathic intracranial hypertension without papilledema (IIHWOP) in chronic refractory headache. Front Neurol. 2018;9:503. (Highlights the prevalence of IIHWOP.)PubMedPubMedCentralCrossRef •• Favoni V, Pierangeli G, Toni F, Cirillo L, La Morgia C, Abu-Rumeileh S, et al. Idiopathic intracranial hypertension without papilledema (IIHWOP) in chronic refractory headache. Front Neurol. 2018;9:503. (Highlights the prevalence of IIHWOP.)PubMedPubMedCentralCrossRef
14.
go back to reference Corbett JJ, Mehta MP. Cerebrospinal fluid pressure in normal obese subjects and patients with pseudotumor cerebri. Neurology. 1983;33(10):1386-. Corbett JJ, Mehta MP. Cerebrospinal fluid pressure in normal obese subjects and patients with pseudotumor cerebri. Neurology. 1983;33(10):1386-.
15.
go back to reference Whiteley W, Al-Shahi R, Warlow CP, Zeidler M, Lueck CJ. CSF opening pressure: reference interval and the effect of body mass index. Neurology. 2006;67(9):1690–1.PubMedCrossRef Whiteley W, Al-Shahi R, Warlow CP, Zeidler M, Lueck CJ. CSF opening pressure: reference interval and the effect of body mass index. Neurology. 2006;67(9):1690–1.PubMedCrossRef
16.
go back to reference • Mollan SP, Chong YJ, Grech O, Sinclair AJ, Wakerley BR. Current perspectives on idiopathic intracranial hypertension without papilloedema. Life. 2021;11(6):472. ()PubMedPubMedCentralCrossRef • Mollan SP, Chong YJ, Grech O, Sinclair AJ, Wakerley BR. Current perspectives on idiopathic intracranial hypertension without papilloedema. Life. 2021;11(6):472. ()PubMedPubMedCentralCrossRef
17.
go back to reference •• Friedman DI, Quiros PA, Subramanian PS, Mejico LJ, Gao S, McDermott M, et al. Headache in idiopathic intracranial hypertension: findings from the idiopathic intracranial hypertension treatment trial. Headache. 2017;57(8):1195–205. ()PubMedPubMedCentralCrossRef •• Friedman DI, Quiros PA, Subramanian PS, Mejico LJ, Gao S, McDermott M, et al. Headache in idiopathic intracranial hypertension: findings from the idiopathic intracranial hypertension treatment trial. Headache. 2017;57(8):1195–205. ()PubMedPubMedCentralCrossRef
18.
go back to reference •• Adderley NJ, Subramanian A, Perrins M, Nirantharakumar K, Mollan SP, Sinclair AJ. Headache, opiate use, and prescribing trends in women with idiopathic intracranial hypertension: a population-based matched cohort study. Neurology. 2022;99(18):e1968–78. ()PubMedPubMedCentralCrossRef •• Adderley NJ, Subramanian A, Perrins M, Nirantharakumar K, Mollan SP, Sinclair AJ. Headache, opiate use, and prescribing trends in women with idiopathic intracranial hypertension: a population-based matched cohort study. Neurology. 2022;99(18):e1968–78. ()PubMedPubMedCentralCrossRef
19.
go back to reference Friedman DI. Headaches in idiopathic intracranial hypertension. J Neuroophthalmol. 2019;39(1):82–93.PubMedCrossRef Friedman DI. Headaches in idiopathic intracranial hypertension. J Neuroophthalmol. 2019;39(1):82–93.PubMedCrossRef
20.
go back to reference De Simone R, Marano E, Bilo L, Briganti F, Esposito M, Ripa P, et al. Idiopathic intracranial hypertension without headache. Cephalalgia. 2006;26(8):1020–1.PubMedCrossRef De Simone R, Marano E, Bilo L, Briganti F, Esposito M, Ripa P, et al. Idiopathic intracranial hypertension without headache. Cephalalgia. 2006;26(8):1020–1.PubMedCrossRef
21.
go back to reference Sina F, Razmeh S, Habibzadeh N, Zavari A, Nabovvati M. Migraine headache in patients with idiopathic intracranial hypertension. Neurol Int. 2017;9(3):7280.PubMedPubMedCentralCrossRef Sina F, Razmeh S, Habibzadeh N, Zavari A, Nabovvati M. Migraine headache in patients with idiopathic intracranial hypertension. Neurol Int. 2017;9(3):7280.PubMedPubMedCentralCrossRef
22.
go back to reference D DA, Curone M, Ciasca P, Cammarata G, Melzi L, Bussone G, et al. Headache prevalence and clinical features in patients with idiopathic intracranial hypertension (IIH). Neurol Sci. 2013;34 Suppl 1:S147–9. D DA, Curone M, Ciasca P, Cammarata G, Melzi L, Bussone G, et al. Headache prevalence and clinical features in patients with idiopathic intracranial hypertension (IIH). Neurol Sci. 2013;34 Suppl 1:S147–9.
23.
go back to reference Onder H, Ulusoy EK, Aslanyavrusu M, Akturk T, Arslan G, Akkurt I, et al. The prevalence of papilledema in patients with migraine: a crucial cooccurrence of migraine and idiopathic intracranial hypertension. Neurol Sci. 2020;41(9):2613–20.PubMedCrossRef Onder H, Ulusoy EK, Aslanyavrusu M, Akturk T, Arslan G, Akkurt I, et al. The prevalence of papilledema in patients with migraine: a crucial cooccurrence of migraine and idiopathic intracranial hypertension. Neurol Sci. 2020;41(9):2613–20.PubMedCrossRef
24.
go back to reference De Simone R, Ranieri A, Montella S, Cappabianca P, Quarantelli M, Esposito F, et al. Intracranial pressure in unresponsive chronic migraine. J Neurol. 2014;261(7):1365–73.PubMedPubMedCentralCrossRef De Simone R, Ranieri A, Montella S, Cappabianca P, Quarantelli M, Esposito F, et al. Intracranial pressure in unresponsive chronic migraine. J Neurol. 2014;261(7):1365–73.PubMedPubMedCentralCrossRef
25.
go back to reference Vieira DS, Masruha MR, Gonçalves AL, Zukerman E, Senne Soares CA, Naffah-Mazzacoratti Mda G, et al. Idiopathic intracranial hypertension with and without papilloedema in a consecutive series of patients with chronic migraine. Cephalalgia. 2008;28(6):609–13.PubMedCrossRef Vieira DS, Masruha MR, Gonçalves AL, Zukerman E, Senne Soares CA, Naffah-Mazzacoratti Mda G, et al. Idiopathic intracranial hypertension with and without papilloedema in a consecutive series of patients with chronic migraine. Cephalalgia. 2008;28(6):609–13.PubMedCrossRef
27.
29.
go back to reference Mollan SP, Ali F, Hassan-Smith G, Botfield H, Friedman DI, Sinclair AJ. Evolving evidence in adult idiopathic intracranial hypertension: pathophysiology and management. J Neurol Neurosurg Psychiatry. 2016;87(9):982–92.PubMedCrossRef Mollan SP, Ali F, Hassan-Smith G, Botfield H, Friedman DI, Sinclair AJ. Evolving evidence in adult idiopathic intracranial hypertension: pathophysiology and management. J Neurol Neurosurg Psychiatry. 2016;87(9):982–92.PubMedCrossRef
30.
go back to reference Markey KA, Uldall M, Botfield H, Cato LD, Miah MA, Hassan-Smith G, et al. Idiopathic intracranial hypertension, hormones, and 11beta-hydroxysteroid dehydrogenases. J Pain Res. 2016;9:223–32.PubMedPubMedCentral Markey KA, Uldall M, Botfield H, Cato LD, Miah MA, Hassan-Smith G, et al. Idiopathic intracranial hypertension, hormones, and 11beta-hydroxysteroid dehydrogenases. J Pain Res. 2016;9:223–32.PubMedPubMedCentral
31.
go back to reference • Wichmann TO, Damkier HH, Pedersen M. A brief overview of the cerebrospinal fluid system and its implications for brain and spinal cord diseases. Front Hum Neurosci. 2021;15: 737217. (An overview of CSF dynamics.)PubMedCrossRef • Wichmann TO, Damkier HH, Pedersen M. A brief overview of the cerebrospinal fluid system and its implications for brain and spinal cord diseases. Front Hum Neurosci. 2021;15: 737217. (An overview of CSF dynamics.)PubMedCrossRef
32.
go back to reference Lenck S, Radovanovic I, Nicholson P, Hodaie M, Krings T, Mendes-Pereira V. Idiopathic intracranial hypertension: the veno glymphatic connections. Neurology. 2018;91(11):515–22.PubMedCrossRef Lenck S, Radovanovic I, Nicholson P, Hodaie M, Krings T, Mendes-Pereira V. Idiopathic intracranial hypertension: the veno glymphatic connections. Neurology. 2018;91(11):515–22.PubMedCrossRef
33.
go back to reference Mondejar V, Patsalides A. The Role of arachnoid granulations and the glymphatic system in the pathophysiology of idiopathic intracranial hypertension. Curr Neurol Neurosci Rep. 2020;20(7):20.PubMedCrossRef Mondejar V, Patsalides A. The Role of arachnoid granulations and the glymphatic system in the pathophysiology of idiopathic intracranial hypertension. Curr Neurol Neurosci Rep. 2020;20(7):20.PubMedCrossRef
34.
go back to reference Leishangthem L, SirDeshpande P, Dua D, Satti SR. Dural venous sinus stenting for idiopathic intracranial hypertension: an updated review. J Neuroradiol. 2019;46(2):148–54.PubMedCrossRef Leishangthem L, SirDeshpande P, Dua D, Satti SR. Dural venous sinus stenting for idiopathic intracranial hypertension: an updated review. J Neuroradiol. 2019;46(2):148–54.PubMedCrossRef
35.
go back to reference De Simone R, Ranieri A, Sansone M, Marano E, Russo CV, Sacca F, et al. Dural sinus collapsibility, idiopathic intracranial hypertension, and the pathogenesis of chronic migraine. Neurol Sci. 2019;40(Suppl 1):59–70.PubMedCrossRef De Simone R, Ranieri A, Sansone M, Marano E, Russo CV, Sacca F, et al. Dural sinus collapsibility, idiopathic intracranial hypertension, and the pathogenesis of chronic migraine. Neurol Sci. 2019;40(Suppl 1):59–70.PubMedCrossRef
36.
go back to reference Friedman DI, Rausch EA. Headache diagnoses in patients with treated idiopathic intracranial hypertension. Neurology. 2002;58(10):1551–3.PubMedCrossRef Friedman DI, Rausch EA. Headache diagnoses in patients with treated idiopathic intracranial hypertension. Neurology. 2002;58(10):1551–3.PubMedCrossRef
37.
go back to reference Togha M, Shirbache K, Rahmanzadeh R, Ghorbani Z, Yari Z, Refaeian F, et al. Prevalence of new-onset migraine in patients with idiopathic intracranial hypertension in comparison to the general population. Iran J Neurol. 2018;17(4):161–6.PubMedPubMedCentral Togha M, Shirbache K, Rahmanzadeh R, Ghorbani Z, Yari Z, Refaeian F, et al. Prevalence of new-onset migraine in patients with idiopathic intracranial hypertension in comparison to the general population. Iran J Neurol. 2018;17(4):161–6.PubMedPubMedCentral
38.
go back to reference Farhadi Z, Alidoost S, Behzadifar M, Mohammadibakhsh R, Khodadadi N, Sepehrian R, et al. The prevalence of migraine in Iran: a systematic review and meta-analysis. Iran Red Crescent Med J. 2016;18(10): e40061.PubMedPubMedCentralCrossRef Farhadi Z, Alidoost S, Behzadifar M, Mohammadibakhsh R, Khodadadi N, Sepehrian R, et al. The prevalence of migraine in Iran: a systematic review and meta-analysis. Iran Red Crescent Med J. 2016;18(10): e40061.PubMedPubMedCentralCrossRef
39.
go back to reference Yri HM, Ronnback C, Wegener M, Hamann S, Jensen RH. The course of headache in idiopathic intracranial hypertension: a 12-month prospective follow-up study. Eur J Neurol. 2014;21(12):1458–64.PubMedCrossRef Yri HM, Ronnback C, Wegener M, Hamann S, Jensen RH. The course of headache in idiopathic intracranial hypertension: a 12-month prospective follow-up study. Eur J Neurol. 2014;21(12):1458–64.PubMedCrossRef
40.
go back to reference Smith SV, Friedman DI. The idiopathic intracranial hypertension treatment trial: a review of the outcomes. Headache. 2017;57(8):1303–10.PubMedCrossRef Smith SV, Friedman DI. The idiopathic intracranial hypertension treatment trial: a review of the outcomes. Headache. 2017;57(8):1303–10.PubMedCrossRef
41.
go back to reference • Mollan SP, Wakerley BR, Alimajstorovic Z, Mitchell J, Ottridge R, Yiangou A, et al. Intracranial pressure directly predicts headache morbidity in idiopathic intracranial hypertension. J Headache Pain. 2021;22(1):118. ()PubMedPubMedCentralCrossRef • Mollan SP, Wakerley BR, Alimajstorovic Z, Mitchell J, Ottridge R, Yiangou A, et al. Intracranial pressure directly predicts headache morbidity in idiopathic intracranial hypertension. J Headache Pain. 2021;22(1):118. ()PubMedPubMedCentralCrossRef
42.
go back to reference van Alphen HA. Migraine, a result of increased CSF pressure: a new pathophysiological concept (preliminary report). Neurosurg Rev. 1986;9(1–2):121–4.PubMedCrossRef van Alphen HA. Migraine, a result of increased CSF pressure: a new pathophysiological concept (preliminary report). Neurosurg Rev. 1986;9(1–2):121–4.PubMedCrossRef
43.
go back to reference Mathew NT, Ravishankar K, Sanin LC. Coexistence of migraine and idiopathic intracranial hypertension without papilledema. Neurology. 1996;46(5):1226–30.PubMedCrossRef Mathew NT, Ravishankar K, Sanin LC. Coexistence of migraine and idiopathic intracranial hypertension without papilledema. Neurology. 1996;46(5):1226–30.PubMedCrossRef
44.
go back to reference De Simone R, Ranieri A. The role of intracranial hypertension in the chronification of migraine. Neurol Sci. 2015;36(Suppl 1):23–8.PubMedCrossRef De Simone R, Ranieri A. The role of intracranial hypertension in the chronification of migraine. Neurol Sci. 2015;36(Suppl 1):23–8.PubMedCrossRef
45.
go back to reference Kelly LP, Saindane AM, Bruce BB, Ridha MA, Riggeal BD, Newman NJ, et al. Does bilateral transverse cerebral venous sinus stenosis exist in patients without increased intracranial pressure? Clin Neurol Neurosurg. 2013;115(8):1215–9.PubMedCrossRef Kelly LP, Saindane AM, Bruce BB, Ridha MA, Riggeal BD, Newman NJ, et al. Does bilateral transverse cerebral venous sinus stenosis exist in patients without increased intracranial pressure? Clin Neurol Neurosurg. 2013;115(8):1215–9.PubMedCrossRef
46.
go back to reference Wall M. The headache profile of idiopathic intracranial hypertension. Cephalalgia. 1990;10(6):331–5.PubMedCrossRef Wall M. The headache profile of idiopathic intracranial hypertension. Cephalalgia. 1990;10(6):331–5.PubMedCrossRef
47.
go back to reference Wall M, George D. Idiopathic intracranial hypertension. A prospective study of 50 patients. Brain. 1991;114 ( Pt 1A):155–80. Wall M, George D. Idiopathic intracranial hypertension. A prospective study of 50 patients. Brain. 1991;114 ( Pt 1A):155–80.
48.
go back to reference Giuseffi V, Wall M, Siegel PZ, Rojas PB. Symptoms and disease associations in idiopathic intracranial hypertension (pseudotumor cerebri): a case-control study. Neurology. 1991;41(2(Pt 1)):239–44. Giuseffi V, Wall M, Siegel PZ, Rojas PB. Symptoms and disease associations in idiopathic intracranial hypertension (pseudotumor cerebri): a case-control study. Neurology. 1991;41(2(Pt 1)):239–44.
49.
go back to reference Vetvik KG, MacGregor EA. Sex differences in the epidemiology, clinical features, and pathophysiology of migraine. Lancet Neurol. 2017;16(1):76–87.PubMedCrossRef Vetvik KG, MacGregor EA. Sex differences in the epidemiology, clinical features, and pathophysiology of migraine. Lancet Neurol. 2017;16(1):76–87.PubMedCrossRef
50.
go back to reference Bruce BB, Kedar S, Van Stavern GP, Monaghan D, Acierno MD, Braswell RA, et al. Idiopathic intracranial hypertension in men. Neurology. 2009;72(4):304–9.PubMedPubMedCentralCrossRef Bruce BB, Kedar S, Van Stavern GP, Monaghan D, Acierno MD, Braswell RA, et al. Idiopathic intracranial hypertension in men. Neurology. 2009;72(4):304–9.PubMedPubMedCentralCrossRef
51.
go back to reference Sacco S, Ricci S, Degan D, Carolei A. Migraine in women: the role of hormones and their impact on vascular diseases. J Headache Pain. 2012;13(3):177–89.PubMedPubMedCentralCrossRef Sacco S, Ricci S, Degan D, Carolei A. Migraine in women: the role of hormones and their impact on vascular diseases. J Headache Pain. 2012;13(3):177–89.PubMedPubMedCentralCrossRef
52.
go back to reference van Oosterhout WPJ, Schoonman GG, van Zwet EW, Dekkers OM, Terwindt GM, MaassenVanDenBrink A, et al. Female sex hormones in men with migraine. Neurology. 2018;91(4):e374–81.PubMed van Oosterhout WPJ, Schoonman GG, van Zwet EW, Dekkers OM, Terwindt GM, MaassenVanDenBrink A, et al. Female sex hormones in men with migraine. Neurology. 2018;91(4):e374–81.PubMed
53.
go back to reference • Ailani J. Updates on management of headache in women and transgender women. Curr Opin Neurol. 2021;34(3):339–43. ()PubMedCrossRef • Ailani J. Updates on management of headache in women and transgender women. Curr Opin Neurol. 2021;34(3):339–43. ()PubMedCrossRef
54.
go back to reference • Thaller M, Wakerley BR, Abbott S, Tahrani AA, Mollan SP, Sinclair AJ. Managing idiopathic intracranial hypertension in pregnancy: practical advice. Pract Neurol. 2022;22(4):295–300. ()PubMedPubMedCentralCrossRef • Thaller M, Wakerley BR, Abbott S, Tahrani AA, Mollan SP, Sinclair AJ. Managing idiopathic intracranial hypertension in pregnancy: practical advice. Pract Neurol. 2022;22(4):295–300. ()PubMedPubMedCentralCrossRef
55.
go back to reference • Park DSJ, Park JSY, Sharma S, Sharma RA. Idiopathic intracranial hypertension in pregnancy. J Obstet Gynaecol Can. 2021;43(11):1292–5. ()PubMedCrossRef • Park DSJ, Park JSY, Sharma S, Sharma RA. Idiopathic intracranial hypertension in pregnancy. J Obstet Gynaecol Can. 2021;43(11):1292–5. ()PubMedCrossRef
56.
go back to reference O’Reilly MW, Westgate CS, Hornby C, Botfield H, Taylor AE, Markey K, et al. A unique androgen excess signature in idiopathic intracranial hypertension is linked to cerebrospinal fluid dynamics. JCI Insight. 2019;4(6). Study evaluating androgen levels in women with IIH. O’Reilly MW, Westgate CS, Hornby C, Botfield H, Taylor AE, Markey K, et al. A unique androgen excess signature in idiopathic intracranial hypertension is linked to cerebrospinal fluid dynamics. JCI Insight. 2019;4(6). Study evaluating androgen levels in women with IIH.
57.
go back to reference • Mollan SP, Tahrani AA, Sinclair AJ. The potentially modifiable risk factor in idiopathic intracranial hypertension: body weight. Neurol Clin Pract. 2021;11(4):e504–7. ()PubMedPubMedCentralCrossRef • Mollan SP, Tahrani AA, Sinclair AJ. The potentially modifiable risk factor in idiopathic intracranial hypertension: body weight. Neurol Clin Pract. 2021;11(4):e504–7. ()PubMedPubMedCentralCrossRef
59.
go back to reference Hornby C, Mollan SP, Botfield H, O’Reilly MW, Sinclair AJ. Metabolic concepts in idiopathic intracranial hypertension and their potential for therapeutic intervention. J Neuroophthalmol. 2018;38(4):522–30.PubMedPubMedCentralCrossRef Hornby C, Mollan SP, Botfield H, O’Reilly MW, Sinclair AJ. Metabolic concepts in idiopathic intracranial hypertension and their potential for therapeutic intervention. J Neuroophthalmol. 2018;38(4):522–30.PubMedPubMedCentralCrossRef
60.
go back to reference May A, Schulte LH. Chronic migraine: risk factors, mechanisms and treatment. Nat Rev Neurol. 2016;12(8):455–64.PubMedCrossRef May A, Schulte LH. Chronic migraine: risk factors, mechanisms and treatment. Nat Rev Neurol. 2016;12(8):455–64.PubMedCrossRef
61.
go back to reference Daniels AB, Liu GT, Volpe NJ, Galetta SL, Moster ML, Newman NJ, et al. Profiles of obesity, weight gain, and quality of life in idiopathic intracranial hypertension (pseudotumor cerebri). Am J Ophthalmol. 2007;143(4):635–41.PubMedCrossRef Daniels AB, Liu GT, Volpe NJ, Galetta SL, Moster ML, Newman NJ, et al. Profiles of obesity, weight gain, and quality of life in idiopathic intracranial hypertension (pseudotumor cerebri). Am J Ophthalmol. 2007;143(4):635–41.PubMedCrossRef
62.
go back to reference • Westgate CSJ, Israelsen IME, Jensen RH, Eftekhari S. Understanding the link between obesity and headache- with focus on migraine and idiopathic intracranial hypertension. J Headache Pain. 2021;22(1):123. ()PubMedPubMedCentralCrossRef • Westgate CSJ, Israelsen IME, Jensen RH, Eftekhari S. Understanding the link between obesity and headache- with focus on migraine and idiopathic intracranial hypertension. J Headache Pain. 2021;22(1):123. ()PubMedPubMedCentralCrossRef
64.
go back to reference • Wang MTM, Bhatti MT, Danesh-Meyer HV. Idiopathic intracranial hypertension: Pathophysiology, diagnosis and management. J Clin Neurosci. 2022;95:172–9. ()PubMedCrossRef • Wang MTM, Bhatti MT, Danesh-Meyer HV. Idiopathic intracranial hypertension: Pathophysiology, diagnosis and management. J Clin Neurosci. 2022;95:172–9. ()PubMedCrossRef
65.
go back to reference Walker CS, Li X, Whiting L, Glyn-Jones S, Zhang S, Hickey AJ, et al. Mice lacking the neuropeptide alpha-calcitonin gene-related peptide are protected against diet-induced obesity. Endocrinology. 2010;151(9):4257–69 (Animal-based study of anti-CGRP role in obesity).PubMedCrossRef Walker CS, Li X, Whiting L, Glyn-Jones S, Zhang S, Hickey AJ, et al. Mice lacking the neuropeptide alpha-calcitonin gene-related peptide are protected against diet-induced obesity. Endocrinology. 2010;151(9):4257–69 (Animal-based study of anti-CGRP role in obesity).PubMedCrossRef
66.
go back to reference • Etefagh HH, Shahmiri SS, Melali H, Sayadi M, Ansari H, Shahzamani A, et al. Bariatric surgery in migraine patients: CGRP level and weight loss. Obes Surg. 2022;32(11):3635–40. ()PubMedCrossRef • Etefagh HH, Shahmiri SS, Melali H, Sayadi M, Ansari H, Shahzamani A, et al. Bariatric surgery in migraine patients: CGRP level and weight loss. Obes Surg. 2022;32(11):3635–40. ()PubMedCrossRef
67.
go back to reference • Jing F, Zou Q, Wang Y, Cai Z, Tang Y. Activation of microglial GLP-1R in the trigeminal nucleus caudalis suppresses central sensitization of chronic migraine after recurrent nitroglycerin stimulation. J Headache Pain. 2021;22(1):86. ()PubMedPubMedCentralCrossRef • Jing F, Zou Q, Wang Y, Cai Z, Tang Y. Activation of microglial GLP-1R in the trigeminal nucleus caudalis suppresses central sensitization of chronic migraine after recurrent nitroglycerin stimulation. J Headache Pain. 2021;22(1):86. ()PubMedPubMedCentralCrossRef
68.
go back to reference Chen J, Wall M. Epidemiology and risk factors for idiopathic intracranial hypertension. Int Ophthalmol Clin. 2014;54(1):1–11.PubMedCrossRef Chen J, Wall M. Epidemiology and risk factors for idiopathic intracranial hypertension. Int Ophthalmol Clin. 2014;54(1):1–11.PubMedCrossRef
69.
go back to reference Thurtell MJ, Trotti LM, Bixler EO, Rye DB, Bliwise DL, Newman NJ, et al. Obstructive sleep apnea in idiopathic intracranial hypertension: comparison with matched population data. J Neurol. 2013;260(7):1748–51.PubMedPubMedCentralCrossRef Thurtell MJ, Trotti LM, Bixler EO, Rye DB, Bliwise DL, Newman NJ, et al. Obstructive sleep apnea in idiopathic intracranial hypertension: comparison with matched population data. J Neurol. 2013;260(7):1748–51.PubMedPubMedCentralCrossRef
70.
go back to reference Tiseo C, Vacca A, Felbush A, Filimonova T, Gai A, Glazyrina T, et al. Migraine and sleep disorders: a systematic review. J Headache Pain. 2020;21(1):126.PubMedPubMedCentralCrossRef Tiseo C, Vacca A, Felbush A, Filimonova T, Gai A, Glazyrina T, et al. Migraine and sleep disorders: a systematic review. J Headache Pain. 2020;21(1):126.PubMedPubMedCentralCrossRef
71.
go back to reference Buse DC, Rains JC, Pavlovic JM, Fanning KM, Reed ML, Manack Adams A, et al. Sleep disorders among people with migraine: results from the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study. Headache. 2019;59(1):32–45.PubMedCrossRef Buse DC, Rains JC, Pavlovic JM, Fanning KM, Reed ML, Manack Adams A, et al. Sleep disorders among people with migraine: results from the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study. Headache. 2019;59(1):32–45.PubMedCrossRef
72.
go back to reference • Yiangou A, Mitchell JL, Nicholls M, Chong YJ, Vijay V, Wakerley BR, et al. Obstructive sleep apnoea in women with idiopathic intracranial hypertension: a sub-study of the idiopathic intracranial hypertension weight randomised controlled trial (IIH: WT). J Neurol. 2022;269(4):1945–56. ()PubMedCrossRef • Yiangou A, Mitchell JL, Nicholls M, Chong YJ, Vijay V, Wakerley BR, et al. Obstructive sleep apnoea in women with idiopathic intracranial hypertension: a sub-study of the idiopathic intracranial hypertension weight randomised controlled trial (IIH: WT). J Neurol. 2022;269(4):1945–56. ()PubMedCrossRef
73.
go back to reference Wall M, McDermott MP, Kieburtz KD, Corbett JJ, Feldon SE, Friedman DI, et al. Effect of acetazolamide on visual function in patients with idiopathic intracranial hypertension and mild visual loss: the idiopathic intracranial hypertension treatment trial. JAMA. 2014;311(16):1641–51.PubMedCrossRef Wall M, McDermott MP, Kieburtz KD, Corbett JJ, Feldon SE, Friedman DI, et al. Effect of acetazolamide on visual function in patients with idiopathic intracranial hypertension and mild visual loss: the idiopathic intracranial hypertension treatment trial. JAMA. 2014;311(16):1641–51.PubMedCrossRef
74.
go back to reference Celebisoy N, Gökçay F, Sirin H, Akyürekli O. Treatment of idiopathic intracranial hypertension: topiramate vs acetazolamide, an open-label study. Acta Neurol Scand. 2007;116(5):322–7.PubMedCrossRef Celebisoy N, Gökçay F, Sirin H, Akyürekli O. Treatment of idiopathic intracranial hypertension: topiramate vs acetazolamide, an open-label study. Acta Neurol Scand. 2007;116(5):322–7.PubMedCrossRef
75.
go back to reference Scotton WJ, Botfield HF, Westgate CS, Mitchell JL, Yiangou A, Uldall MS, et al. Topiramate is more effective than acetazolamide at lowering intracranial pressure. Cephalalgia. 2019;39(2):209–18.PubMedCrossRef Scotton WJ, Botfield HF, Westgate CS, Mitchell JL, Yiangou A, Uldall MS, et al. Topiramate is more effective than acetazolamide at lowering intracranial pressure. Cephalalgia. 2019;39(2):209–18.PubMedCrossRef
76.
go back to reference Mollan SP, Davies B, Silver NC, Shaw S, Mallucci CL, Wakerley BR, et al. Idiopathic intracranial hypertension: consensus guidelines on management. J Neurol Neurosurg Psychiatry. 2018;89(10):1088–100.PubMedCrossRef Mollan SP, Davies B, Silver NC, Shaw S, Mallucci CL, Wakerley BR, et al. Idiopathic intracranial hypertension: consensus guidelines on management. J Neurol Neurosurg Psychiatry. 2018;89(10):1088–100.PubMedCrossRef
77.
go back to reference • Yiangou A, Mitchell JL, Fisher C, Edwards J, Vijay V, Alimajstorovic Z, et al. Erenumab for headaches in idiopathic intracranial hypertension: a prospective open-label evaluation. Headache. 2021;61(1):157–69. An open-label study of an anti-CGRP medication in IIH. • Yiangou A, Mitchell JL, Fisher C, Edwards J, Vijay V, Alimajstorovic Z, et al. Erenumab for headaches in idiopathic intracranial hypertension: a prospective open-label evaluation. Headache. 2021;61(1):157–69. An open-label study of an anti-CGRP medication in IIH.
Metadata
Title
Overlap and Differences in Migraine and Idiopathic Intracranial Hypertension
Authors
Sweta Sengupta
Jaskiran Vidwan
Publication date
01-09-2023
Publisher
Springer US
Published in
Current Pain and Headache Reports / Issue 11/2023
Print ISSN: 1531-3433
Electronic ISSN: 1534-3081
DOI
https://doi.org/10.1007/s11916-023-01166-7

Other articles of this Issue 11/2023

Current Pain and Headache Reports 11/2023 Go to the issue

Chronic Daily Headache (S-J Wang and S-P Chen, Section Editors)

Non-Pharmacological Treatment for Chronic Migraine

Anesthetic Techniques in Pain Management (D Wang, Section Editor)

SPECT/CT Scan: A New Diagnostic Tool in Pain Medicine

Secondary Headache (M Robbins, Section Editor)

Headache in leptomeningeal metastases

Anesthetic Techniques in Pain Management (D Wang, Section Editor)

Neurostimulation therapies for chronic pain